Royalty Pharma(MX:RPRXN)
MX$1,213.520.00 (0.00%)
MX:RPRXN
Royalty Pharma earnings date
MX$1,213.52
At close:0.00 (0.00%)
Royalty Pharma (RPRXN) Q4 2021 Earnings Report
1 Followers
MX:RPRXN Q4 2021 EPS Results
- Actual EPS
- MXN 14.88
- Consensus EPS
- MXN 14.41
- Beat/Miss
- Beat by +MXN 0.46
- One Year Ago EPS
- MXN 12.96
MX:RPRXN Q4 2021 Revenue Results
- Actual Revenue
- MXN 10.71B
- Expected Revenue
- MXN 10.27B
- Beat/Miss
- Beat by +MXN 445.20M
- YoY Revenue Growth
- +0.70%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 02/15/2022
- Time
- Before Open
- Conference Call
- Tuesday, February 15, 2022
MX:RPRXN Upcoming Earnings
Royalty Pharma's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RPRXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 29.13- | 27.27 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 21.9722.47 | 21.82 | 2.98% (+0.65) | |
| Aug 05, 2026 | 2026 (Q2) | 23.6824.57 | 21.22 | 15.78% (+3.35) | |
| May 06, 2026 | 2026 (Q1) | 22.5824.11 | 13.93 | 73.03% (+10.17) | |
| Feb 11, 2026 | 2025 (Q4) | 23.9227.27 | 21.41 | 27.37% (+5.86) | |
| Nov 05, 2025 | 2025 (Q3) | 18.4921.82 | 17.06 | 27.92% (+4.76) | |
| Aug 06, 2025 | 2025 (Q2) | 19.2021.22 | 17.87 | 18.73% (+3.35) | |
| May 08, 2025 | 2025 (Q1) | 17.7313.93 | 18.19 | -23.42% (-4.26) | |
| Feb 11, 2025 | 2024 (Q4) | 19.6221.41 | 21.37 | 0.17% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | 17.2417.06 | 14.68 | 16.22% (+2.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
